Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty

NCT03316482 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Central Precocious Puberty

Interventions

DRUG: Leuplin DPS 11.25mg

Sponsor

Jin Soon Hwang